TEEJAY TRIPP: Open Payments
NPI 1629308424 · SANDY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,025 in 115 payments from 21 companies in 2025. Trend: 2023 $2,800 · 2024 $2,788 · 2025 $2,025
Food & beverage: $2,025
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $373 |
| ABBVIE INC. | 25 | $322 |
| Corium, LLC | 11 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $205 |
| Vanda Pharmaceuticals Inc. | 9 | $145 |
| Supernus Pharmaceuticals, Inc. | 4 | $92 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Tris Pharma Inc | 4 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $66 |
Products named: VRAYLAR, Azstarys, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, FANAPT, Qelbree, Jornay PM.
Industry payments across GA — which companies pay providers there.
